AWM
CVS icon

Abound Wealth Management’s CVS Health CVS Stock Holding History

Abound Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.51K Sell
92
-183
-67% -$16.3K ﹤0.01% 476
2026
Q1 		$19.8K Sell
275
-4
-1% -$308 ﹤0.01% 407
2025
Q4 		$22.1K Buy
279
+84
+43% +$6.62K 0.01% 341
2025
Q3 		$14.7K Buy
195
+1
+0.5% +$69 ﹤0.01% 418
2025
Q2 		$13.4K Hold
194
– – ﹤0.01% 390
2025
Q1 		$13.2K Sell
194
-96
-33% -$5.75K ﹤0.01% 361
2024
Q4 		$13K Sell
290
-194
-40% -$10.9K ﹤0.01% 349
2024
Q3 		$30.5K Buy
484
+222
+85% +$13K 0.01% 228
2024
Q2 		$15.5K Sell
262
-3
-1% -$188 0.01% 297
2024
Q1 		$21.2K Sell
265
-19
-7% -$1.45K 0.01% 238
2023
Q4 		$22.4K Buy
284
+58
+26% +$4.13K 0.01% 231
2023
Q3 		$15.8K Buy
226
+23
+11% +$1.63K 0.01% 250
2023
Q2 		$14.1K Buy
203
+27
+15% +$1.92K 0.01% 280
2023
Q1 		$13.1K Buy
176
+39
+28% +$3.27K 0.01% 254
2022
Q4 		$12.8K Sell
137
-81
-37% -$7.82K 0.01% 228
2022
Q3 		$20.8K Buy
+218
New +$21.6K 0.01% 180

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Abound Wealth Management's CVS Position: Q2 2026 in Review

Abound Wealth Management reduced its CVS Health (CVS) stake by 67% in Q2 2026, selling an estimated $16.3K and leaving 92 shares worth $9.51K. The position accounts for ﹤0.01% of the portfolio, ranked #476.

Abound Wealth Management first reported a position in CVS in Q3 2022 and has held it in 16 quarters since. The position peaked at $30.5K in Q3 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Abound Wealth Management held 92 shares of CVS Health worth $9.51K as of Q2 2026.
  • Abound Wealth Management sold 183 CVS Health shares in Q2 2026, an estimated $16.3K.
  • CVS Health made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #476 holding.
  • Abound Wealth Management first reported a position in CVS Health in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's CVS Health position peaked at $30.5K in Q3 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.